Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients
Clinical trial NCT03547830 · UNKNOWN
Trial details
- NCT number
- NCT03547830
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-13
- Primary completion
- 2023-01-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.